Home » Topics » Regulatory

Regulatory
RSS

Preclinical studies further define effects underlying tranilast's efficacy in preventing restenosis

Jan. 15, 2001

Provalis obtains U.K. marketing rights to Pennsaid topical solution

Jan. 12, 2001

FDA approves Femara for first-line treatment of breast cancer

Jan. 11, 2001

Expanded phase III trial program in bipolar disorder announced for Seroquel

Jan. 10, 2001

Argatroban sNDA filed for HIT patients undergoing PCI

Jan. 10, 2001

IND submitted for salmon calcitonin as oral osteoporosis treatment

Jan. 9, 2001

Marketing agreement with Bioglan for Solaraze expanded by SkyePharma

Jan. 8, 2001

U.K. MCA grants marketing clearance for Periostat tablets

Jan. 5, 2001

Major advances in infertility treatment announced by Serono

Jan. 5, 2001

Remicade is first drug approved for inhibiting progression of joint damage in RA

Jan. 3, 2001

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026